FdaApplication
ANDA 220268
Identifiers
- fda_app_no: ANDA220268
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS INC USA |
| application_type | ANDA |
| approval_date | 2026-01-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LACOSAMIDE | LACOSAMIDE | 200MG/20ML (10MG/ML) | SOLUTION;INTRAVENOUS |
1 product